Petmedix Ltd, Cambridge

Petmedix Ltd is a private limited company. Located at The Glenn Berge Building, Building 940 Babraham Research Campus, Babraham, Cambridge CB22 3FH, the aforementioned 6 years old business was incorporated on 2017-12-05 and is classified as "research and experimental development on biotechnology" (SIC: 72110).
3 directors can be found in the enterprise: Julie B. (appointed on 03 August 2023), Ben B. (appointed on 03 August 2023), Chad R. (appointed on 03 August 2023).
About
Name: Petmedix Ltd
Number: 11095804
Incorporation date: 2017-12-05
End of financial year: 30 November
 
Address: The Glenn Berge Building, Building 940 Babraham Research Campus
Babraham
Cambridge
CB22 3FH
SIC code: 72110 - Research and experimental development on biotechnology
Company staff
People with significant control
Zoetis Inc
3 August 2023
Address 10 Sylvan Way, Parsippany, New Jersey, 07054, United States
Legal authority General Corporation Law Of The State Of Delaware
Legal form Corporate
Country registered Delaware
Place registered New York Stock Exchange
Registration number 5118663
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors
Parkwalk Advisors Limited
13 September 2021 - 3 August 2023
Address 3 Pancras Square, London, N1C 4AG, United Kingdom
Legal authority Companies Act 2006
Legal form Private Limited Company
Country registered England
Place registered Companies House
Registration number 06925696
Nature of control: 25-50% voting rights
25-50% shares
Companion Fund I Llc
27 February 2019 - 13 September 2021
Address 11 Times Square Suite 1500a, New York, 10036, United States
Legal authority United States
Legal form Llc
Country registered Usa/New York
Place registered Central Registration Depository (Crd)
Registration number Crd # 283347
Nature of control: 25-50% voting rights
25-50% shares
Parkwalk Advisors Ltd
27 February 2019 - 15 May 2020
Address University House 11-13 Lower Grosvenor Place, London, SW1W 0EX, England
Legal authority Companies Act 2006
Legal form Private Limited Company
Country registered England
Place registered Companies House
Registration number 06925696
Nature of control: 25-50% voting rights
25-50% shares
Kymab Limited
21 February 2019 - 27 February 2019
Address The Bennet Building (B930) Babraham Research Centre, Cambridge, CB22 3AT, England
Legal authority Companies Act 2006
Legal form Private Limited Company
Country registered England
Place registered England And Wales
Registration number 07027523
Nature of control: 25-50% voting rights
25-50% shares
Thomas W.
5 December 2017 - 27 February 2019
Nature of control: 75,01-100% shares
Allan B.
18 June 2018 - 27 February 2019
Nature of control: 25-50% shares
Financial data
Date of Accounts 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Current Assets 316,259 6,297,861 7,117,152 29,639,094 23,282,578
Fixed Assets 10,263 410,638 1,013,581 1,140,751 1,061,519
Total Assets Less Current Liabilities -137,456 6,236,057 5,971,930 28,790,711 23,254,426

The due date for Petmedix Ltd confirmation statement filing is 2023-11-22. The most recent confirmation statement was sent on 2022-11-08. The date for a subsequent statutory accounts filing is 31 August 2024. Last accounts filing was submitted for the time period up to 31 December 2022.

7 persons of significant control are listed in the official register, namely: Zoetis Inc has over 3/4 of shares, 3/4 to full of voting rights. The corporate PSC can be found at Sylvan Way, 07054 Parsippany, New Jersey. Parkwalk Advisors Limited has 1/2 or less of shares, 1/2 or less of voting rights. The corporate PSC can be found at Pancras Square, N1C 4AG London. Companion Fund I Llc has 1/2 or less of shares, 1/2 or less of voting rights. The corporate PSC can be found at Suite 1500A, 10036 New York.

Company filing
Filter filings by category:
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Director appointment termination date: 2023-08-03
filed on: 16th, November 2023 | officers
Free Download (1 page)